These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17381182)

  • 1. When should clozapine be initiated in schizophrenia?: Some arguments for and against earlier use of clozapine.
    Kerwin R
    CNS Drugs; 2007; 21(4):267-78. PubMed ID: 17381182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing nonresponse in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2012 Feb; 73(2):e07. PubMed ID: 22401484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
    Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
    JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study.
    Üçok A; Çıkrıkçılı U; Ergül C; Tabak Ö; Salaj A; Karabulut S; Correll CU
    CNS Drugs; 2016 Oct; 30(10):997-1006. PubMed ID: 27356920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.
    Hofer A; Hummer M; Kemmler G; Kurz M; Kurzthaler I; Fleischhacker WW
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):201-6. PubMed ID: 12974985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
    Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J
    BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine].
    Inada K; Ishigooka J
    Nihon Rinsho; 2013 Apr; 71(4):678-83. PubMed ID: 23678599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.
    Nakajima S; Takeuchi H; Fervaha G; Plitman E; Chung JK; Caravaggio F; Iwata Y; Mihashi Y; Gerretsen P; Remington G; Mulsant B; Graff-Guerrero A
    Schizophr Res; 2015 Feb; 161(2-3):429-33. PubMed ID: 25556080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
    Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
    Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment-resistant schizophrenia].
    Yahyaten OB
    Rev Med Brux; 2014; 35(3):169-73. PubMed ID: 25102584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine vs. other atypical antipsychotics for schizophrenia.
    Kripke C
    Am Fam Physician; 2011 Feb; 83(3):260-1. PubMed ID: 21302867
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising use of minocycline augmentation with clozapine in treatment-resistant schizophrenia.
    Qurashi I; Collins JD; Chaudhry IB; Husain N
    J Psychopharmacol; 2014 Jul; 28(7):707-8. PubMed ID: 24646811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing treatment with clozapine.
    Conley RR
    J Clin Psychiatry; 1998; 59 Suppl 3():44-8. PubMed ID: 9541338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation strategies in clozapine-resistant schizophrenia.
    Remington G; Saha A; Chong SA; Shammi C
    CNS Drugs; 2005; 19(10):843-72. PubMed ID: 16185094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age on the relative efficacy of clozapine in schizophrenia.
    Jones R; MacCabe JH; Price MJ; Liu X; Upthegrove R
    Acta Psychiatr Scand; 2020 Aug; 142(2):109-120. PubMed ID: 31977065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine.
    Lieberman JA; Phillips M; Gu H; Stroup S; Zhang P; Kong L; Ji Z; Koch G; Hamer RM
    Neuropsychopharmacology; 2003 May; 28(5):995-1003. PubMed ID: 12700715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.
    Wimberley T; MacCabe JH; Laursen TM; Sørensen HJ; Astrup A; Horsdal HT; Gasse C; Støvring H
    Am J Psychiatry; 2017 Oct; 174(10):990-998. PubMed ID: 28750580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.